0000899243-20-014729.txt : 20200601
0000899243-20-014729.hdr.sgml : 20200601
20200601163146
ACCESSION NUMBER: 0000899243-20-014729
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200528
FILED AS OF DATE: 20200601
DATE AS OF CHANGE: 20200601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATRICK DEVAL L
CENTRAL INDEX KEY: 0001053466
STANDARD INDUSTRIAL CLASSIFICATION: AIR TRANSPORTATION, SCHEDULED [4512]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 20933770
MAIL ADDRESS:
STREET 1: BAIN CAPITAL, LLC
STREET 2: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-28
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001053466
PATRICK DEVAL L
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
68.75
2020-05-28
4
A
0
625
0.00
A
2030-05-27
Common Stock
625
625
D
Restricted Stock Units
2020-05-28
4
A
0
2400
0.00
A
Common Stock
2400
2400
D
The shares subject to this option shall vest and become exercisable in a single installment on June 28, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on June 28, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
/s/ Tricia Suvari, as Attorney-in-Fact
2020-06-01